Go back to MDS Pharma Services home page

Skip Navigation LinksHome / Services / Bioanalysis / Large Molecule Bioanalysis
Large Molecule Bioanalysis


MDS Pharma Services leads the industry with extensive breadth and depth of experience in providing ligand binding services support to over 100 pharmaceutical companies. With more than 50 new validated methods per annum, we are leaders in supporting bioanalysis for biopharmaceutical products.

Our global senior laboratory management team brings an average of 15 years’ expertise, while our laboratory analysts have an average of nine years bench experience with MDS Pharma Services. The quality of our scientific staff is strongly complemented by our highly effective sample custody, project management, quality assurance and IT teams.

Our ligand binding services experience includes:


  • Therapeutic proteins (pegylated/unpegylated)
  • Peptides
  • Antibodies

Cell-Based Assays

  • Neutralizing Ab testing
  • Potency assays


  • Endogenous biomolecules
  • Cytokines and chemokines
  • Vascular and growth factors
  • Bone markers
  • Metabolic markers

Our experience allows us to find the right assay to meet the clinical and regulatory needs for our clients.

State-of-the-art technology
  • Enzyme immunoassay (EIA)
  • Radioimmunoassay
  • Surface plasmon resonance
  • Cell-based assays
  • Molecular biology
State-of-the-art equipment
  • Biacore 3000
  • Meso Scale Sector Imager 2400
  • BIO-RAD / BioPlex (Luminex)
  • Molecular Devices (MDS Analytical Technologies) Spectramax 384
  • Gemini XPS plate readers
  • Top Count NXT radioisotopic and chemiluminescence readers

Quality On Time™

Our mission at MDS Pharma Services is to continuously improve to a greater than 95% On Time performance. Since the implementation of LeanSigma, this commitment to continuous improvement is exemplified by our high success rate in developing ELISA and RIA assays with a greater than 95% “right the first time” pass rate.

Skip Navigation Links. Skip Navigation Links.

Related Services

Development and Regulatory Services
Preclinical and Discovery
Early Clinical Research
Global Clinical Development


© 2009 MDS Pharma Services     |     Corporate Governance     |     Legal     |     Privacy     |     Site Map